Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
www.frontiersin.org
06 July 2021 Autologous and allogenic mesenchymal stem cells (MSCs) are so far the best candidates for use in regenerative medicine. They can be separated, expanded in vitro, and implanted from autologous or allogenic sources In the last 10 years, the mechanism of MSC action has been gradually clari
1 Users
0 Comments
7 Highlights
0 Notes
Top Highlights
- 06 July 2021
- Autologous and allogenic mesenchymal stem cells (MSCs) are so far the best candidates for use in regenerative medicine.
- They can be separated, expanded in vitro, and implanted from autologous or allogenic sources
- In the last 10 years, the mechanism of MSC action has been gradually clarified
- SCI caused by various pathologies and accidents often lead to permanent disabilities or death. MSCs and their secretomes are, therefore, accessible therapeutic tools for regenerative medicine, also including central nervous system (CNS) pathologies.
Domain
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.